Cockburn I, Henderson R
Faculty of Commerce and Business Administration, University of British Columbia, Vancouver, Canada.
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12725-30. doi: 10.1073/pnas.93.23.12725.
We empirically examine interaction between the public and private sectors in pharmaceutical research using qualitative data on the drug discovery process and quantitative data on the incidence of coauthorship between public and private institutions. We find evidence of significant reciprocal interaction, and reject a simple "linear" dichotomous model in which the public sector performs basic research and the private sector exploits it. Linkages to the public sector differ across firms, reflecting variation in internal incentives and policy choices, and the nature of these linkages correlates with their research performance.
我们使用药物研发过程的定性数据以及公共和私人机构之间共同署名发生率的定量数据，对制药研究中公共部门与私人部门之间的相互作用进行实证研究。我们发现了显著的相互作用的证据，并拒绝了一种简单的“线性”二分模型，即公共部门进行基础研究，私人部门加以利用。与公共部门的联系因公司而异，反映出内部激励和政策选择的差异，而且这些联系的性质与其研究绩效相关。
